Skip to main content
    J

    Jupiter Neurosciences, Inc. Common Stock (JUNS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.70
    -0.06 (-3.41%)

    Market Cap: $2.32M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    14%(1/7)
    Avg Surprise
    -35.07%
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Sep 26
    Reported Nov 13
    N/AN/AN/A-----
    Jun 26
    Reported Aug 14
    -$5.06N/AN/A-----7128.6%
    Mar 26
    Reported Apr 1
    -$4.39-$3.76-$3.76 - -$3.76-16.68%Miss1
    No revisions (30d)
    -8672.8%
    Dec 25
    Reported Feb 25
    -$0.07-$0.06N/A-24.67%Miss---49.6%
    Sep 25
    Reported Nov 14
    -$0.07-$0.08-$0.08 - -$0.08+12.50%Beat1
    No revisions (30d)
    -250.0%
    Jun 25
    Reported Aug 18
    -$0.07-$0.07N/A0.00%In line--+0.0%
    Mar 25
    Reported May 15
    -$0.05-$0.03N/A-66.67%Miss---66.7%
    Dec 24
    Reported Mar 28
    -$0.05-$0.02N/A-150.00%Miss---
    Sep 24
    Reported Dec 23
    -$0.02-$0.02N/A0.00%In line---
    Dec 21
    Reported Mar 30
    -$0.07N/AN/A-----
    Sep 21
    Reported Nov 9
    -$0.03N/AN/A-----

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-15167.00%
    ROE-1889.00%ROIC1154.48%
    Financial Health
    Debt/Equity-0.19xInterest Coverage-30.10x
    Current Ratio0.49xQuick Ratio0.44x
    Trading Statistics
    BetaN/AAvg Volume18.57K
    52-Week High$101.2552-Week Low$1.76

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 36.4% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.6, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$2.11
    SMA 20$2.35
    SMA 50$2.67
    SMA 200$17.38
    EMA 10$2.05
    EMA 20$2.28
    EMA 50$3.36
    EMA 200$20.63

    MACD

    Line: -0.31Signal: -0.27Hist: -0.04

    ADX

    ADX: 19.5+DI: 13.8-DI: 24.0

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$2.39

    Bollinger Bands

    Upper Band$3.07
    Lower Band$1.63
    %B Position6153%(Upper)
    Band Width0.05

    RSI (14-Day)

    Neutral
    30.6

    Momentum Oscillators

    Stoch %K4.2
    Stoch %D7.1
    Williams %R-93.5
    ROC (10d)-26.4%
    Momentum-0.61
    CCI (20d)-155.0
    MFI (14d)27.3

    Volatility Measures

    ATR (14d)$0.34(20.0%)
    StdDev (20d)0.36
    Hist Vol122.2%(High)

    Volume Flow

    VWAP$1.72
    OBV281.8M
    AD Line500.5B
    CMF (20d)-0.267

    Volume Metrics

    Avg Vol (20d)19.1K
    Vol Ratio0.6x
    VWMA (20d)$2.35

    Pivot Points

    R3$1.99
    R2$1.95
    R1$1.85
    Pivot Point$1.81
    S1$1.71
    S2$1.67
    S3$1.57

    Advanced Oscillators

    TSI-26.93
    Ultimate Osc32.9
    KST-240.66

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about JUNS

    News

    JUNS Valuation

    GNG's valuation label for JUNS is Undervalued. It trades at 28.6x forward earnings.

    Forward P/E
    28.6x
    P/B
    -1.4x
    All JUNS metrics

    JUNS Profitability: Margins, ROIC and FCF

    Jupiter Neurosciences, Inc. Common Stock (JUNS) has a gross margin of 79.5%, an operating margin of -15167.0% and a net margin of 0.0%. It posts 1154.5% ROIC and a -11210.5% FCF margin.

    Gross margin
    79.5%
    Operating margin
    -15167.0%
    Net margin
    0.0%
    ROIC
    1154.5%
    ROE
    -1889.0%
    FCF margin
    -11210.5%
    JUNS financial statements

    Jupiter Neurosciences, Inc. Common Stock Competitors

    The companies most similar to Jupiter Neurosciences, Inc. Common Stock (JUNS) include Revelation Biosciences, Neurosense Therapeutics and BioRestorative Therapies.

    Sector: Healthcare

    Companies most similar to Jupiter Neurosciences, Inc. Common Stock

    JUNS Bull Case vs Bear Case

    Bull case

    • JUNS earns a 1154.5% return on invested capital.

    Bear case

    • JUNS beat EPS estimates in 14.3% of its last 7 reported quarters.

    JUNS Earnings: Beat Rate

    Jupiter Neurosciences, Inc. Common Stock (JUNS) beat the EPS estimate in 1 of the 7 most recent quarters that had an estimate (14.3%).

    Beat rate
    1 of 7 quarters (14.3%)
    Average surprise
    -35.1%

    JUNS ETF Holders

    Updated Nov 16, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About JUNS

    Does JUNS pay dividends?

    Jupiter Neurosciences, Inc. Common Stock (JUNS) does not currently pay a regular dividend.

    What is JUNS's market cap?

    Jupiter Neurosciences, Inc. Common Stock (JUNS) has a market capitalization of $2.32M with a current stock price of $1.70.

    Is JUNS stock overvalued?

    GNG's valuation label for JUNS is Undervalued. Jupiter Neurosciences, Inc. Common Stock (JUNS) trades at 28.6x forward earnings.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.